2013
DOI: 10.1016/j.yasu.2013.03.001
|View full text |Cite
|
Sign up to set email alerts
|

What Is the Optimal Means of Staging Colon Cancer?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 44 publications
0
6
0
Order By: Relevance
“…Furthermore, our analyses revealed that NBF1-stage had a 50.4% increased risk of cancer-specific mortality in colon cancer, which rose to 77.1% in non-metastatic colon cancer. Distinguishing between stages IIIA-NBF0 and IIIA-NBF1 in the TNM stage IIIA accounted for the improved prognosis of TNM stage IIIA than IIA [ 2 , 10 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Furthermore, our analyses revealed that NBF1-stage had a 50.4% increased risk of cancer-specific mortality in colon cancer, which rose to 77.1% in non-metastatic colon cancer. Distinguishing between stages IIIA-NBF0 and IIIA-NBF1 in the TNM stage IIIA accounted for the improved prognosis of TNM stage IIIA than IIA [ 2 , 10 ].…”
Section: Discussionmentioning
confidence: 99%
“…The prognosis of patients with malignant colon cancer is influenced both by disease factors and patient-related factors, including biological factors and nonbiological factors (NBFs). The effect of different biological factors, such as American Joint Committee on Cancer (AJCC) staging system, microsatellite instability (MSI) status, and tumor grade on the survival of patients with colon cancer has been widely studied [ 2 , 3 , 4 ]. Several studies have demonstrated that NBFs, such as marital status [ 5 , 6 ], health insurance [ 7 , 8 ], and employment [ 9 ] were associated with the survival of patients with colon cancer.…”
Section: Introductionmentioning
confidence: 99%
“…As to date, the 7 th edition is used and the 8 th edition is on its way. Even the TNM system is based on the anatomical characteristics of the tumour, including tumour spread throughout the bowel wall, the spread to lymph nodes and the presence of metastatic disease 23 .…”
Section: Stagingmentioning
confidence: 99%
“…Fortunately, the P-stage could distinguish well between stages I–P0 and I–P1 in the TNM stage I, and extremely well between stages IIIA–P0 and IIIA–P1 in the TNM stage IIIA (which also seemed to account for the better prognosis of TNM stage IIIA than stage IIIA). 2 , 21 Moreover, toxicity and adverse events caused by adjuvant chemotherapy could result in significant patient morbidity. 22 The present study suggested that the recommendation of reduced chemotherapy in stage IIIA–P0 deserves further investigation and prospective studies with the incorporation of the newly proposed P-stage.…”
Section: Discussionmentioning
confidence: 99%